Sino Biopharmaceutical Ltd. - ADR
SBHMY
Market Cap$18.03B
Close$
$0.54
97.3% downside
Current Fair Value
97.3% downsideOvervalued by 97.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18.03 Billion |
|---|---|
| Enterprise Value | $18.24 Billion |
| Dividend Yield | $0.31 (1.48%) |
| Earnings per Share | $4 |
| Beta | 0.64 |
| Outstanding Shares | 862,222,222 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 36.54 |
|---|---|
| PEG | 58.22 |
| Price to Sales | 1.06 |
| Price to Book Ratio | 0.41 |
| Enterprise Value to Revenue | 1.09 |
| Enterprise Value to EBIT | 7.16 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sino Biopharmaceutical Ltd.
CEO: Ping Tse